Doximity (NYSE:DOCS) is identified as one of the most promising mid-cap healthcare stocks under $50, with Bank of America analyst Allen Lutz reiterating a Buy rating and $82 price target, indicating an 88% upside potential for investors.

Lutz cites Doximity’s accelerating growth in healthcare provider budgets and increased focus on HCP advertising, a shift from meager growth in direct-to-consumer advertising. Digital video initiatives are seen as a growth catalyst for the company.

Analysts show positive sentiment for Doximity (NYSE:DOCS) after an 18% drop in 2025, with 8 Buy ratings, 5 Holds, and 2 Sells. The consensus 1-year price target is $66.62 per share, suggesting a 52.6% upside from current levels.

Doximity (NYSE:DOCS) offers online networking services for healthcare professionals, covering 80% of U.S. physicians. Their AI-powered platform enables HIPAA-compliant communication among medical professionals, highlighting the company’s role in efficient healthcare networking.

While Doximity (NYSE:DOCS) shows investment potential, other AI stocks with greater upside potential and lower risk exist. A focus on undervalued AI stocks benefiting from current economic trends could yield better returns for investors.

Read more at Yahoo Finance: Why BofA Sees Strong Upside for Doximity (DOCS)